- AU$19.27m
- AU$15.86m
- AU$0.27m
Australia's Opyl jumps on service agreement with pharma co Commercial Eyes
Brief: Opyl Signs New Service Agreement With Commercial Eyes
Brief: Opyl Ltd Signs New Service Agreement With Biointelect
Brief: Opyl Ltd Announces Non-Exclusive Strategic Partnership With The Compendium By Phenix Health
Brief: Opyl Enters Strategic Partnership With Alithia Life Sciences
Australia's Opyl gains on MoU with consortium for expansion
Brief: Opyl Signs MOU For EMEA & U.S. Expansion
Brief: Opyl Partners With L39 Capital To Launch AI Biotech Fund
Australia's Opyl jumps on first revenue from AI clinical trial platform
Australia's Opyl jumps on expanded dataset for AI platform
Brief: Opyl Signs Binding Agreement For Sale Of Opin Business
Australia's Opyl gains most in 3-1/2 years on trial recruitment platform sale
Brief: Opyl Receives Non-Binding Offer For Its Opin Business
Brief: Opyl Seeks Trading Halt
Brief: ASX Says Trading Halt In Opyl Shares
Brief: Opyl Says Resignation Of Non-Executive Chair
Australia's Opyl jumps as brand signs patient recruitment contract
Australia's Opyl rises on commitments to cover share placement shortfall
Brief: Opyl Says Received Commitments To Raise Up To A$1.43 Mln